• 主页
  • 查找结果
  • The bioconcentration and bioaccumulation factors for molybdenum in the aquatic environment from natural environmental concentrations up to the toxicity boundary.

The bioconcentration and bioaccumulation factors for molybdenum in the aquatic environment from natural environmental concentrations up to the toxicity boundary.

The Science of the total environment (2012-08-01)
Lidia Regoli, Wim Van Tilborg, Dagobert Heijerick, William Stubblefield, Sandra Carey
摘要

In a regulatory context, bioaccumulation or bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. In this paper, literature data on the bioaccumulation of molybdenum in the aquatic organisms are reviewed and assessed for relevance and reliability. The data available in the literature were generated at exposure concentrations below those recommended in the REACH registration dossiers for molybdenum compounds i.e. PNEC(freshwater) 12.7 mg Mo/L. To address possible environmental concerns at regulatorily-relevant molybdenum concentrations, both a field study and a laboratory study were conducted. In the field study, whole body and organ-specific molybdenum levels were evaluated in fish (eel, stickleback, perch, carp bream, roach) held in the discharge water collector tanks of a molybdenum processing plant, containing a mean measured molybdenum level of 1.03 mg Mo/L. In the laboratory study, rainbow trout were exposed to two different nominal molybdenum levels (1.0 and 12.7 mg Mo/L), for 60 days followed by a 60-day depuration period. Whole body concentrations in rainbow trout during the exposure period were between <0.20 and 0.53 mg Mo/L. Muscle tissue molybdenum concentrations in fish taken from both experiments remained below 0.2mg/kg dry wt. These studies show an inverse relationship between exposure concentration and bioconcentration or bioaccumulation factor for molybdenum. In aquatic organisms, and in fish in particular, internal molybdenum concentrations are maintained in the presence of variation in external molybdenum concentrations. These observations must be considered when evaluating potential risks associated with the bioconcentration and/or bioaccumulation of molybdenum in the aquatic environment.

材料
货号
品牌
产品描述

Sigma-Aldrich
钼, powder, <150 μm, 99.9% trace metals basis
Sigma-Aldrich
钼, foil, thickness 0.1 mm, ≥99.9% trace metals basis
Sigma-Aldrich
钼, powder, <150 μm, 99.99% trace metals basis
Sigma-Aldrich
钼, powder, 1-5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
钼, nanopowder, <100 nm particle size (TEM), 99.8% trace metals basis
Sigma-Aldrich
钼, wire, diam. 1.0 mm, 99.95% trace metals basis
Sigma-Aldrich
钼, foil, thickness 1.0 mm, ≥99.9% trace metals basis
Sigma-Aldrich
钼, foil, thickness 0.025 mm, ≥99.9% trace metals basis
钼, wire reel, 100m, diameter 0.5mm, annealed, 99.95%
钼, foil, 6mm disks, thickness 0.5mm, annealed, 99.9%
钼, foil, 6mm disks, thickness 0.75mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.005mm, 99.9%
钼, foil, 8mm disks, thickness 0.006mm, 99.9%
钼, foil, 8mm disks, thickness 0.007mm, 99.9%
钼, foil, 8mm disks, thickness 0.008mm, 99.9%
钼, foil, 8mm disks, thickness 0.009mm, 99.9%
钼, foil, 8mm disks, thickness 0.0125mm, 99.9%
钼, foil, 8mm disks, thickness 0.015mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.015mm, as rolled, 99.9%
钼, foil, 8mm disks, thickness 0.01mm, 99.9%
钼, foil, 8mm disks, thickness 0.01mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.020mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.025mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.03mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.05mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.075mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.125mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.15mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.1mm, annealed, 99.9%
钼, foil, 8mm disks, thickness 0.20mm, annealed, 99.9%

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。